ClinicalTrials.Veeva

Menu

Angiotensin-Converting Enzyme Polymorphism and Acute Renal Failure (ECAREA)

C

Caen University Hospital

Status

Terminated

Conditions

Critical Illness
Kidney Failure, Acute

Treatments

Procedure: Blood sampling for PCR

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Associations between angiotensin-converting enzyme gene polymorphism and occurrence and outcome of ARDS, and with respiratory complications post cardiopulmonary bypass have already been demonstrated. Based on physiological effects of angiotensin II, we hypothesized that the I allele of the angiotensin-converting enzyme Insertion/Deletion polymorphism may be associated with a higher risk of acute renal failure in critically ill patients.

Full description

Associations between angiotensin-converting enzyme gene polymorphism and occurrence and outcome of ARDS, and with respiratory complications post cardiopulmonary bypass have already been demonstrated. Based on physiological effects of angiotensin II, we hypothesized that the I allele of the angiotensin-converting enzyme Insertion/Deletion polymorphism may be associated with a higher risk of acute renal failure in critically ill patients.

Enrollment

160 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age > 18 yrs
  • ICU stay > 48 hours

Exclusion criteria

  • Age < 18 yrs
  • Creatinine > 180 µmol/L
  • Absence of consent

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems